Latest Stock Research & Market Analysis
Stock Research
Pro Medicus (ASX: PME) – A Secular SaaS Growth Story
Pro Medicus (ASX: PME) is a health tech software company providing imaging tools and services to clients such as hospitals, diagnostic chains, and independent practices. The company's growth was significantly boosted by the logistical disruptions of the COVID-19...
Amcor (ASX: AMC) – Poised To Re-rate On Better Macro Conditions
Amcor (ASX: AMC) has had a rough couple of years owing to high rates and inflation, which crippled customer spending and changed spending patterns. Given the high volume and commoditized nature of Amcor’s business, revenues and earnings...
Harvey Norman (ASX: HVN) – A Low-Risk Play Geared To Consumption
Harvey Norman (ASX: HVN) is one of Australia’s household retail names with a large physical presence in the ANZ region and parts of Asia and Europe. The company has been suffering over the past couple of years from a cost of living crisis that crippled demand and...
NextDC (ASX: NXT): A Shovel In The AI Gold Rush
NextDC (ASX: NXT) is a data center operator riding a massive cloud/digitization wave for the past decade. Over the past decade, the company has grown tremendously as businesses of all sizes moved from on-premises computing to cloud service providers like AWS, Oracle,...
Suncorp (ASX: SUN) – Smooth Ride Ahead
Suncorp is a major general insurance firm operating in the ANZ region. After a rough couple of years due to inflation and heightened claims, the company is back on track with a strong modernization program to drive efficiency and better macro conditions. Moderating...
Subscribe
Want more Free Research?
Subscribe today for free and get an alert when we have new research and webinars.
Top Stock Reports
5 Best Shares to Buy Right Now in Australia
Finding the best shares to buy right now can be challenging, especially in a volatile market. For Australian investors, identifying opportunities on the ASX (Australian Securities Exchange) requires careful consideration of both short-term performance and long-term...
5 Best Dividend Stocks to Buy [ASX Blue Chip Stocks]
When it comes to dividend investing, finding the best dividend stocks on the ASX can provide both reliable income and long-term portfolio resilience. The ASX offers a diverse range of high dividend stocks, including market leaders with stable revenues and a track...
5 Best Lithium Stocks ASX 2023 [Australian Lithium Stocks]
Today, we will look at some of the best lithium stocks on the ASX 200 to buy for 2023. These Australian lithium stocks have great leverage to one of the fastest growing sectors in Australia. Lithium is a massively growing industry with the advent of clean energy and...
Opinions & Guides
Here is How a Repeatable Pattern Gave Investors 24% Gain in Wesfarmers Stock in 6 Months
Part of stock analysis involves undertaking fundamental analysis, technical analysis or a combination of both. Although, it would be nice if everything was as simple as black and white without any inconsistency. For instance, mathematical measures of intrinsic value...
Is the RBA done with rate hikes?
They say, “hope for the best, and be prepared for the worst”. This is the message that Lowe appeared to be sending last week to mortgage holders, telling the world that interest rates “may well” rise again. Given the balance of risks and the outrage resulting from...
Why the RBA Should Press Pause on Rate Hikes… Soon
The Reserve Bank (RBA) has been in a tough spot lately. Yes, it misread the economy in the aftermath of the pandemic. But the RBA wasn’t the only central bank that went all out in providing stimulus. It wasn’t just the RBA that was late in recognising inflation risks....
Testimonials
What People are Saying...
See what people are saying about our research, products and services.
[brb_collection id="81368"]
MF & Co. Asset Management
MF & Co. Asset Management is a boutique investment firm offering Equity Capital Markets and derivative general advice & trade execution services.
We are specialists in advising and trading in Australian and US Equities, Index & Equity Options and Options on Futures.
Contact
Get In Touch
Australia
1300 889 603
International
+61 2 8378 7199
M-F: 8am-5pm
Suite 803, Level 8
70 Pitt St, Sydney, NSW 2000